A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors

被引:396
作者
Voorhoeve, PM
le Sage, C
Schrier, M
Gillis, AJM
Stoop, H
Nagel, R
Liu, YP
van Duijse, J
Drost, J
Griekspoor, A
Zlotorynski, E
Yabuta, N
De Vita, G
Nojima, H
Looijenga, LHJ
Agami, R
机构
[1] Netherlands Canc Inst, Div Tumour Biol, Amsterdam, Netherlands
[2] Erasmus Univ, Med Ctr Rotterdam, Dr Daniel Denhoed Canc Ctr, Dept Pathol,Josephine Nefkens Inst, Rotterdam, Netherlands
[3] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, CEINGE Biotecnol Avanzate, Naples, Italy
[4] Osaka Univ, Dept Mol Genet, Osaka, Japan
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Endogenous small RNAs (miRNAs) regulate gene expression by mechanisms conserved across metazoans. While the number of verified human miRNAs is still expanding, only few have been functionally annotated. To perform genetic screens for novel functions of miRNAs, we developed a library of vectors expressing the majority of cloned human miRNAs and created corresponding DNA barcode arrays. In a screen for miRNAs that cooperate with oncogenes in cellular transformation, we identified miR-372 and miR-373, each permitting proliferation and tumorigenesis of primary human cells that harbor both oncogenic RAS and active wild-type p53. These miRNAs neutralize p53-mediated CDK inhibition, possibly through direct inhibition of the expression of the tumor-suppressor LATS2. We provide evidence that these miRNAs are potential novel oncogenes participating in the development of human testicular germ cell tumors by numbing the p53 pathway, thus allowing tumorigenic growth in the presence of wild-type p53.
引用
收藏
页码:1169 / 1181
页数:13
相关论文
共 50 条
[1]
Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage [J].
Agami, R ;
Bernards, R .
CELL, 2000, 102 (01) :55-66
[2]
Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling [J].
Almstrup, K ;
Hoei-Hansen, CE ;
Wirkner, U ;
Blake, J ;
Schwager, C ;
Ansorge, W ;
Nielsen, JE ;
Skakkebæk, NE ;
Meyts, ERD ;
Leffers, H .
CANCER RESEARCH, 2004, 64 (14) :4736-4743
[3]
Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation [J].
Bagga, S ;
Bracht, J ;
Hunter, S ;
Massirer, K ;
Holtz, J ;
Eachus, R ;
Pasquinelli, AE .
CELL, 2005, 122 (04) :553-563
[4]
Oncogene-induced senescence as an initial barrier in lymphoma development [J].
Braig, M ;
Lee, S ;
Loddenkemper, C ;
Rudolph, C ;
Peters, AHFM ;
Schlegelberger, B ;
Stein, H ;
Dörken, B ;
Jenuwein, T ;
Schmitt, CA .
NATURE, 2005, 436 (7051) :660-665
[5]
A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[6]
Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines [J].
Burger, H ;
Nooter, K ;
Boersma, AWM ;
Kortland, CJ ;
Stoter, G .
BRITISH JOURNAL OF CANCER, 1998, 77 (10) :1562-1567
[7]
MicroRNAs modulate hematopoietic lineage differentiation [J].
Chen, CZ ;
Li, L ;
Lodish, HF ;
Bartel, DP .
SCIENCE, 2004, 303 (5654) :83-86
[8]
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis [J].
Chen, ZB ;
Trotman, LC ;
Shaffer, D ;
Lin, HK ;
Dotan, ZA ;
Niki, M ;
Koutcher, JA ;
Scher, HI ;
Ludwig, T ;
Gerald, W ;
Cordon-Cardo, C ;
Pandolfi, PP .
NATURE, 2005, 436 (7051) :725-730
[9]
Tumour biology -: Senescence in premalignant tumours [J].
Collado, M ;
Gil, J ;
Efeyan, A ;
Guerra, C ;
Schuhmacher, AJ ;
Barradas, M ;
Benguría, A ;
Zaballos, A ;
Flores, JM ;
Barbacid, M ;
Beach, D ;
Serrano, M .
NATURE, 2005, 436 (7051) :642-642
[10]
Dose-dependent inhibition of thyroid differentiation by RAS oncogenes [J].
De Vita, G ;
Bauer, L ;
da Costa, VMC ;
De Felice, M ;
Baratta, MG ;
De Menna, M ;
Di Lauro, R .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (01) :76-89